Filter
2268
Filtered Results: 2268
Text search:
receiving
medicines
Featured
Recommendations
232
New Publications
680
Language
Document type
No document type
1327
Studies & Reports
329
Guidelines
295
Manuals
124
Strategic & Response Plan
82
Training Material
34
Fact sheets
34
Situation Updates
27
Infographics
13
Resource Platforms
2
Brochures
1
Countries / Regions
India
135
Kenya
79
Global
74
South Africa
65
Ethiopia
55
Nepal
53
Uganda
50
Tanzania
44
Bangladesh
44
Western and Central Europe
43
Zambia
41
Malawi
41
Ukraine
41
Myanmar / Burma
41
Liberia
40
Sierra Leone
39
Ghana
38
Nigeria
36
Latin America and the Carribbean
33
Africa
33
Rwanda
30
Syria
29
Namibia
28
Zimbabwe
24
Eastern Europe
21
Congo, Democratic Republic of
20
Mozambique
18
Venezuela
18
South–East Asia Region
15
Philippines
14
Cambodia
14
East and Southern Africa
14
Asia
14
Botswana
12
Lesotho
12
Senegal
11
West and Central Africa
11
Russia
11
Pakistan
9
South Sudan
8
Eswatini/ Swaziland
8
Middle East and North Africa
8
Moldova
8
Burkina Faso
7
Yemen
7
Lebanon
6
Indonesia
6
Colombia
6
Western Pacific Region
6
Guinea
5
Cameroon
5
Haiti
5
Brazil
5
Eastern Europe and Central Asia
5
Vietnam
5
Afghanistan
4
North Macedonia
4
Poland
4
Albania
4
Laos
4
Georgia
4
Somalia
3
Jordan
3
Germany
3
Sudan
3
Benin
3
Central African Republic
3
Peru
3
Hungary
3
Sri Lanka
3
Tajikistan
3
Romania
3
Jamaica
3
United Kingdom
3
Saudi Arabia
2
Chad
2
Thailand
2
Gambia
2
Argentina
2
Madagascar
2
Paraguay
2
Bhutan
2
Palestine
2
Southern Africa
2
Timor Leste/ East Timor
2
Iran
2
Kyrgyzstan
2
Mauritius
2
Morocco
1
USA
1
Togo
1
Iraq
1
Turkey
1
Egypt
1
Papua New Guinea
1
Serbia
1
El Salvador
1
Bolivia
1
Libya
1
Mexico
1
Chile
1
Other region
1
Fiji
1
Djibouti
1
Armenia
1
Mongolia
1
Canada
1
Qatar
1
Bulgaria
1
Lithuania
1
Slovakia
1
Kazakhstan
1
North America
1
Turkmenistan
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
997
Clinical Guidelines
230
Public Health
119
Women & Child Health
110
Capacity Building
49
Key Resources
48
Pharmacy & Technologies
21
Annual Report MEDBOX
2
Toolboxes
HIV
275
TB
180
COVID-19
161
Mental Health
127
Pharmacy
86
AMR
73
Conflict
64
Caregiver
64
Ebola
46
Disability
42
NCDs
41
Refugee
36
NTDs
33
Rapid Response
32
Global Health Education
27
Natural Hazards
19
Health Financing Toolbox
17
Planetary Health
13
Polio
8
Cholera
4
Zika
2
Specific Hazards
2
Social Ethics
2
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral <... for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections.
The listings aim to address global health priorities, identifying the medicines that provide the greatest benefits, and which should be available and affordable for all. However, high prices for both new, patented medicines and older medicines, like insulin, continue to keep some essential medicines out of reach for many patients.
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential ... (EML) and the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s...
This field study to measure access to and use of medicines was undertaken in GHANA in May-June 2008. The study assessed information on the socio-economic level of households, and access to and use of ... for acute and chronic conditions as well as opinions and perceptions about medicines. The survey was conducted in six regions. In each region, six reference public heath care facilities were selected among those participating in the Level II Facility Survey that was carried out in parallel. Within defined distances from each reference public health care facility, households were selected by purposive cluster sampling. A total of 1065 household respondents were interviewed by means of a structured paper questionnaire
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of...
Agodokpessi et al. Journal of Pharmaceutical Policy and Practice (2015) 8:12DOI 10.1186/s40545-015-0033-7
Benin established a revolving drug fund (RDF) for essential asthma medicines in 2008. We evaluated
the operation of the RDF and assessed wh...
PMPB/INS-GUIDE/01
Accessed November 2017
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines<...
